Tyagarajan Seshu (CIK 0001923794)

Latest company ownership

CADL - Candel Therapeutics, Inc.

Role: Chief Technology Officer

Shares held

90,865

Last filed at

Jun 26, 2025

Confidence Score

49.4

2025Q4

Confidence Score History

2022Q4 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Mar 17, 2025	Mar 20, 2025	Candel Therapeutics, Inc.	Chief Technology Officer	Sell	7.5	-31,278	-26.78%	✓	$275.9K
Mar 17, 2025	Mar 19, 2025	Candel Therapeutics, Inc.	Chief Technology Officer	Sell	7.5	-31,278	-26.78%	✓	$275.9K
Jan 15, 2025	Jan 17, 2025	Candel Therapeutics, Inc.	Chief Technology Officer	Sell	42.5	-14,322	-12.89%	✗	$103.5K
Jan 8, 2025	Jan 10, 2025	Candel Therapeutics, Inc.	Chief Technology Officer	Sell	42.5	-14,545	-11.58%	✗	$119.5K
Nov 29, 2024	Dec 3, 2024	Candel Therapeutics, Inc.	Chief Technology Officer	Sell	42.5	-20,392	-13.96%	✗	$92.9K
Jul 17, 2024	Jul 19, 2024	Candel Therapeutics, Inc.	Chief Technology Officer	Sell	42.5	-14,851	-9.23%	✗	$96.1K
Jul 11, 2024	Jul 15, 2024	Candel Therapeutics, Inc.	Chief Technology Officer	Sell	42.5	-13,330	-7.65%	✗	$79.6K
Nov 28, 2023	Nov 30, 2023	Candel Therapeutics, Inc.	Chief Technology Officer	Sell	46.3	-17,328	-9.05%	✗	$15.6K
Dec 8, 2022	Dec 12, 2022	Candel Therapeutics, Inc.	Chief Technology Officer	Buy	91.3	+13,358	100.00%	✗	$25.1K